Cambridge research receives £5 million for groundbreaking cardiovascular research

Cambridge University has been awarded 5 million by the British Heart Foundation to support cutting-edge research into cardiovascular diseases. This funding will enable researchers to collaborate, innovate, and drive breakthroughs in the field. Professor Martin Bennett, a leading expert in Cardiovascular Sciences at the University of Cambridge, expressed excitement over the award, emphasizing the importance of identifying new targets and treatments for conditions like vascular disease, heart failure, diabetes, and obesity.

The funding is part of a larger 35 million investment by the British Heart Foundation into cardiovascular disease research in the UK. It aims to support researchers at Cambridge in various ways, including identifying new markers for diseases, conducting clinical trials for new drugs, developing innovative diagnostic tools, and utilizing artificial intelligence to predict risk factors. This funding highlights the commitment to promoting collaboration and innovation in the field of cardiovascular research.

Professor Bryan Williams, the Chief Scientific and Medical Officer at the British Heart Foundation, praised the ongoing research at Cambridge and emphasized the impact of such funding in attracting top talent, advancing scientific discoveries, and addressing critical challenges in heart and circulatory diseases. The Research Excellence Awards provide scientists with the flexibility to launch ambitious projects and foster interdisciplinary collaborations, ultimately paving the way for groundbreaking discoveries.